Epiodyne, Inc.
Biotechnology company · San Francisco, California, United States
Epiodyne, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2016. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $8 million sold in a notice filed in 2019.
Epiodyne at a glance
What does Epiodyne do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2018 to 2022). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $8 million sold (2019).
Frequently asked questions about Epiodyne
Where is Epiodyne headquartered?
Epiodyne, Inc. is headquartered in San Francisco, California, United States.
What does Epiodyne do?
Epiodyne, Inc. is a biotechnology company.
When was Epiodyne founded?
The earliest incorporation on record for Epiodyne, Inc. is in 2016, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences